7-Hydroxyamoxapine
![]()  | |
| Pharmacokinetic data | |
|---|---|
| Elimination half-life | 6.5 hours | 
| Identifiers | |
IUPAC name 
  | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C17H16ClN3O2 | 
| Molar mass | 329.78 g·mol−1 | 
| 3D model (JSmol) | |
SMILES 
  | |
InChI 
  | |
7-Hydroxyamoxapine is an active metabolite of the antidepressant drug amoxapine (Asendin). It contributes to amoxapine's pharmacology.[1][2] It is a dopamine receptor antagonist and contributes to amoxapine's antipsychotic properties.[3][4]
See also
References
- ↑ Jue SG, Dawson GW, Brogden RN (July 1982). "Amoxapine: a review of its pharmacology and efficacy in depressed states". Drugs. 24 (1): 1–23. doi:10.2165/00003495-198224010-00001. PMID 7049659. S2CID 7279867.
 - ↑ Calvo B, García MJ, Pedraz JL, Mariño EL, Domínguez-Gil A (April 1985). "Pharmacokinetics of amoxapine and its active metabolites". International Journal of Clinical Pharmacology, Therapy, and Toxicology. 23 (4): 180–185. PMID 3997304.
 - ↑ Midha KK, Hubbard JW, McKay G, Rawson MJ, Hsia D (September 1999). "The role of metabolites in a bioequivalence study II: amoxapine, 7-hydroxyamoxapine, and 8-hydroxyamoxapine". International Journal of Clinical Pharmacology and Therapeutics. 37 (9): 428–438. PMID 10507241.
 - ↑ Cohen BM, Harris PQ, Altesman RI, Cole JO (September 1982). "Amoxapine: neuroleptic as well as antidepressant?". The American Journal of Psychiatry. 139 (9): 1165–1167. doi:10.1176/ajp.139.9.1165. PMID 6126130.
 
| 5-HT1ARTooltip 5-HT1A receptor agonists | |
|---|---|
| GABAARTooltip GABAA receptor PAMsTooltip positive allosteric modulators | 
  | 
| Hypnotics | |
| Gabapentinoids (α2δ VDCC blockers)  | |
| Antidepressants | 
  | 
| Antipsychotics | |
| Sympatholytics (Antiadrenergics)  | 
  | 
| Others | |
  | |
| Typical | 
 
  | 
|---|---|
| Disputed | |
| Atypical | 
 
 
  | 
| Others | 
  | 
  | |
Adrenergic receptor modulators  | |||||
|---|---|---|---|---|---|
| α1 | 
  | ||||
| α2 | 
  | ||||
| β | 
  | ||||
  | |||||
| D1-like | 
  | ||||||
|---|---|---|---|---|---|---|---|
| D2-like | 
  | ||||||
  | |||||||
Histamine receptor modulators  | |||||
|---|---|---|---|---|---|
| H1 | 
  | ||||
| H2 | 
  | ||||
| H3 | 
  | ||||
| H4 | 
  | ||||
  | |||||
Serotonin receptor modulators  | |||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5-HT1 | 
  | ||||||||||||||||||||||||||||||||||||||
| 5-HT2 | 
  | ||||||||||||||||||||||||||||||||||||||
| 5-HT3–7 | 
  | ||||||||||||||||||||||||||||||||||||||
  | |||||||||||||||||||||||||||||||||||||||
| Classes | 
  | 
|---|---|
| Antidepressants (Tricyclic antidepressants (TCAs))  | 
  | 
| Antihistamines | 
  | 
| Antipsychotics | 
  | 
| Anticonvulsants | |
| Anticholinergics | |
| Others | 
  | 
    This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
